The Advisory Committee on Immunization Practices (ACIP) is a group of medical and public health experts that develop recommendations on use of vaccines in the civilian population of the United States…
June 21-22, 2017
Deadline for registration:
Non-US Citizens: May 22, 2017, 5:00pm ET (No exceptions)
US Citizens: June 7, 2017, 5:00pm ET
Registration is NOT required to watch the live meeting webcast or to listen via telephone.
Complete list of ACIP recommendations published in the MMWR.
Links to the childhood, adolescent, catch-up, and adult immunization schedules; plus vaccine recording and screening forms.
GRADE (Grading of Recommendations Assessment, Development & Evaluation)
Find tables referenced in ACIP recommendations published in MMWR and learn about GRADE.
General Committee-related Information
Defines ACIP's purpose, authority, and function; its structure, meetings, and compensation; plus costs, reports, and termination.
Membership roster, including chair, executive secretary, voting members, ex officio members, and liaison representatives.
Nominations for future vacancies on ACIP
Procedure for nomination of candidates for ACIP membership.
- Nominations for future vacancies on ACIP
Journal articles about the ACIP.
ACIP Guidance for Economics Studies
Procedures for review of economic analyses to be presented to the ACIP.
ACIP Guidance for Vaccine Recommendations for Pregnant & Breastfeeding Women
Guiding principles for development of ACIP recommendations for vaccination of pregnant and breastfeeding women.
- ACIP Vaccine Acronyms
This ACIP flyer [2 pages] answers questions such as what does the ACIP consider in the vaccine recommendation process, including recommended ages for administration of various vaccines to children?
Updated Guidance for Yellow Fever Vaccine
To avoid a lapse in yellow fever vaccine availability in the United States, the manufacturer, Sanofi Pasteur, has received approval from FDA to import Stamaril yellow fever vaccine. Stamaril is produced by Sanofi Pasteur in France and has comparable safety and efficacy to YF-Vax. See the MMWR Addressing a Yellow Fever Vaccine Shortage — United States, 2016–2017 for further information for providers regarding yellow fever vaccine.
- Page last reviewed: April 15, 2016
- Page last updated: May 8, 2017
- Content source: